| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |